DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis

Decoy receptor 3 (DcR3) is abnormally up-regulated in many cancer cells. It may help cancer cells to escape from immune surveillance and establish metastatic lesions. However, whether DcR3 can be used as a biomarker for the diagnosis of cancer metastasis is unclear. In this study, sera from healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junxin, Xie, Ni, Yuan, Jianhui, Liu, Lvyan, Zhou, Qiming, Ren, Xiaohu, Chen, Qian, Zhang, Guizhong, Ruan, Qingguo, Chen, Youhai H., Wan, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746094/
https://www.ncbi.nlm.nih.gov/pubmed/29296192
http://dx.doi.org/10.18632/oncotarget.22544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746094/
https://www.ncbi.nlm.nih.gov/pubmed/29296192
http://dx.doi.org/10.18632/oncotarget.22544

Ejemplares similares